Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer

2 participants · First posted Sep 16, 2014

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

183 participants · First posted Apr 10, 2025

Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer

40 participants · First posted Dec 17, 2014

Pamrevlumab

Gemcitabine/Paclitaxel

Surufatinib

C₂₄H₂₈N₆O₃S · Rx

Shanghai Yizhong Pharmaceutical Co., Ltd.

Ambev SA

Brazil

Sichuan Huiyu Pharmaceutical Co., Ltd.

Phase I GlutaPanc Trial: l-Glutamine Plus Gemcitabine/Nab-Paclitaxel Shows Promising Efficacy in Advanced Pancreatic Cancer

Immuneering Doses First Patient in Phase III MAPKeeper 301 Trial of Atebimetinib Plus Modified Gemcitabine/Nab-Paclitaxel in Metastatic Pancreatic Cancer

Immuneering's IMM-1-104 Shows Promise in Phase 2a Trial for Pancreatic Cancer